When treated with AD-PHF seeds, only Tau-expressing cells contained aggregated Tau after 48 h of treatment (Fig. 6a) indicating specific aggregation of overexpressed Tau, rather than the accumulation of exogenous seed material. This evidence concerns the gene MAPT and Alzheimer disease.